Actively Recruiting
Assessment of Anterior Cruciate Ligament (ACL) Degeneratio Mucosa Treatment
Led by Artromedical Konrad Malinowski Clinic · Updated on 2023-01-27
10
Participants Needed
1
Research Sites
234 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Anterior Cruciate Ligament (ACL) Degeneratio Mucosa is a condition resulting from mucoid degeneration of ACL. Exact etiology is unknown, however ACL Degeneratio Mucosa impairs everyday functioning. In the literature there were some reports of treatment by ACL excision and subsequent reconstruction, however such treatment brings risk of deteriorated function. In this study the investigator will evaluate the technique of ACL "decompression" by the means of longitudinal incisions and evacuation of extrafibrous mucoid tissue.
CONDITIONS
Official Title
Assessment of Anterior Cruciate Ligament (ACL) Degeneratio Mucosa Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with ACL degeneratio mucosa decided to undergo a surgical treatment
- Range of motion impairment caused by mucoid or cystic changes in ACL confirmed by MRI
You will not qualify if you...
- Non-adherence to the study protocol
- Active knee inflammation
- Range of motion impairment due to other extra- and intra-articular reasons
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Artromedical Orthopaedic Clinic
Bełchatów, Łódź Voivodeship, Poland, 97-400
Actively Recruiting
Research Team
K
Konrad Malinowski, MD PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here